glycyrrhizic acid has been researched along with carbenoxolone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Du, L; Feng, Y; Leng, Y; Shen, J; Yang, H; Zhang, X; Zhou, Z | 1 |
Amer, H; Beseda, I; Classen-Houben, D; Czollner, L; Da Cunha, T; Del Ruiz-Ruiz, MC; Gaware, R; Jordis, U; Khunt, R; Kosma, P; Mereiter, K; Odermatt, A; Shah, PS; Stanetty, C | 1 |
Hao, XJ; He, HP; Leng, Y; Li, SF; Mpetga, JD; Shen, Y; Tane, P; Tene, M; Wabo, HK | 1 |
Chen, J; Leng, Y; Ning, M; Shen, J; Zhang, L; Zou, Q | 1 |
4 other study(ies) available for glycyrrhizic acid and carbenoxolone
Article | Year |
---|---|
4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Benzamides; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Discovery; Humans; Hydrolysis; Inhibitory Concentration 50; Mice; Mice, Obese; Models, Chemical; Structure-Activity Relationship; Sulfonamides | 2009 |
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Crystallography, X-Ray; Glycyrrhetinic Acid; Humans; Metabolic Diseases; Models, Molecular | 2010 |
Cycloartane and friedelane triterpenoids from the leaves of Caloncoba glauca and their evaluation for inhibition of 11β-hydroxysteroid dehydrogenases.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Cameroon; Humans; Mice; Plant Leaves; Salicaceae; Triterpenes | 2012 |
Synthesis and evaluation of piperidine urea derivatives as efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Mice; Mice, Obese; Molecular Structure; Piperidines; Structure-Activity Relationship; Urea | 2012 |